Anúncio
Anúncio
RAPT
RAPT Therapeutics, Inc. Common Stock
33.62
USDPatrocinado
+2.35
+7.54%
09 de jan., 15:59 UTC -5
Encerrado
Pré-Mercado
33.56
-0.06
-0.18%
Relatórios de Lucros RAPT
Rácio de surpresa positiva
RAPT separação 17 de 25 últimas estimativas.
68%
Próximo Relatório
Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.76
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+16.92%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-91.66%
RAPT Therapeutics, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, RAPT reported earnings of -0.65 USD per share (EPS) for Q3 25, beating the estimate of -0.94 USD, resulting in a 31.56% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analistas forecast an EPS of -0.76 USD, with revenue projected to reach -- USD, implying an aumentar of 16.92% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were RAPT Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, RAPT Therapeutics, Inc. Common Stock reported EPS of -$0.65, beating estimates by 31.56%, and revenue of $0.00, 0% as expectations.
How did the market react to RAPT Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 2.72%, changed from $28.27 before the earnings release to $29.04 the day after.
When is RAPT Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 04 de mar. de 2026.
What are the forecasts for RAPT Therapeutics, Inc. Common Stock's next earnings report?
Based on 11
analistas, RAPT Therapeutics, Inc. Common Stock is expected to report EPS of -$0.76 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio